Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug reSistant patients with Tipranavir (RESIST) studies: an analysis of combined data from two randomised open-label trials. (Record no. 16479062)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02306 a2200589 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250515035023.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200608s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1474-547X |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1016/S0140-6736(06)69154-X |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Hicks, Charles B |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20060822 |
245 00 - TITLE STATEMENT | |
Title | Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug reSistant patients with Tipranavir (RESIST) studies: an analysis of combined data from two randomised open-label trials. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Lancet (London, England) |
Date of publication, distribution, etc. | Aug 2006 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 466-75 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Resistance, Viral |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Therapy, Combination |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Enfuvirtide |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | HIV Envelope Protein gp41 |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | HIV Fusion Inhibitors |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | HIV Infections |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | HIV Protease Inhibitors |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | HIV-1 |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Logistic Models |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Multicenter Studies as Topic |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Peptide Fragments |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pyridines |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pyrones |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Randomized Controlled Trials as Topic |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Ritonavir |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sulfonamides |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Time Factors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Failure |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Viral Load |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cahn, Pedro |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cooper, David A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Walmsley, Sharon L |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Katlama, Christine |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Clotet, Bonaventura |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lazzarin, Adriano |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Johnson, Margaret A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Neubacher, Dietmar |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mayers, Douglas |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Valdez, Hernan |
773 0# - HOST ITEM ENTRY | |
Title | Lancet (London, England) |
Related parts | vol. 368 |
-- | no. 9534 |
-- | p. 466-75 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1016/S0140-6736(06)69154-X">https://doi.org/10.1016/S0140-6736(06)69154-X</a> |
Public note | Available from publisher's website |
No items available.